Inhibikase Therapeutics Stock Forecast

Buy candidate since Jul 17, 2026 Gain 11.37%

The Inhibikase Therapeutics, Inc. stock price gained 0.86% on the last trading day (Monday, 27th Jul 2026), rising from $2.33 to $2.35. During the last trading day the stock fluctuated 3.24% from a day low at $2.32 to a day high of $2.39. The price has risen in 5 of the last 10 days and is up by 19.9% over the past 2 weeks. Volume fell on the last day by -2 million shares and in total, 507 thousand shares were bought and sold for approximately $1.19 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $2.37 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 17.52% during the next 3 months and, with a 90% probability hold a price between $2.16 and $2.78 at the end of this 3-month period.

IKT Signals & Forecast

The Inhibikase Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.25 and $1.94. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 49.68%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Inhibikase Therapeutics, Inc. stock

Inhibikase Therapeutics, Inc. finds support from accumulated volume at $2.33 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0750 between high and low, or 3.24%. For the last week the stock has had daily average volatility of 6.40%.

Our recommended stop-loss: $2.28 (-3.10%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 46 days ago.)

Trading Expectations (IKT) For The Upcoming Trading Day Of Tuesday 28th

For the upcoming trading day on Tuesday, 28th we expect Inhibikase Therapeutics, Inc. to open at $2.35, and during the day (based on 14 day Average True Range), to move between $2.28 and $2.42, which gives a possible trading interval of +/-$0.134 (+/-5.89%) up or down from last closing price. If Inhibikase Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.89% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $2.33, some $0.0200 (0.85%) from the current price of $2.35, our system finds the risk reward attractive.

Is Inhibikase Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Inhibikase Therapeutics, Inc. stock to perform well in the short-term.

Current score: 4.109 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 28, 2026 - $2.35 ( 0.0709%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk